top of page


Circadian Logo 72dpi.png

Developing products to target diseases associated with circadian rhythm disruption

  • Planning and execution of multiple drug development projects products; a re-purposed molecule targeting an orphan disease and NCEs aimed at more widespread targets

  • Planning and execution of device development and industrialisation

  • Management of suppliers and monitoring of non-clinical trails, cost control

  • Measurement and reporting of progress across portfolio

  • Strategic planning and fundraising support 

  • Data, technology and web site management

 “Labrador brings a diverse skill set and experience that are particularly important to companies at an early stage of development. The bespoke consultancy partnership with Labrador continues to work extremely well as we evolve, Nick is a pleasure to work with.”

Nigel Jones, MD Circadian Therapeutics


Developing products associated with microbiological detection

  • Management of product development interfacing with remote development team

  • Introduction of AWS hosting and service management

  • Programme planning and measurement

  • Product validation and product launch support

  • Implementation of QMS and ISO9001

 “ Nick brings a maturity and reliability which, complemented by his keen eye for detail, make him a highly valued member of the team. He has supported our business in addressing a number of urgent challenges during a period of rapid growth, from system architecture oversight to planning systems. I know I can trust Nick to deliver efficiently and effectively.

Andrew Davies, MD Microgenetics

Ampha high-resolution.jpg

Developing NCEs targeting metabolic diseases

  • Planning and management of offshore NCE development programmes

  • Supplier sourcing and management

  • Strategic and tactical planning support

  • Technology and data management, GDPR support

“I have worked with Nick for many years in a small company environment that operates on a virtual basis. The work covered IT support, R&D project planning, as well as administrative support.


Throughout the period I found Nick trustworthy, efficient and pleasant.”

Rolf Stahel, former CEO Shire Pharmaceuticals

Chairman Ampha

bottom of page